Activity of STAMP inhibitors in ABL2 rearranged acute lymphoblastic leukemia is dependent on the Abl2 SH3 domain
Abstract: ABL2 rearranged (ABL2r) acute lymphoblastic leukemia (ALL) is a subtype of high-risk Philadelphia chromosome–like ALL. Patients with ABL2r ALL are treated with high-dose multiagent chemotherapy, and the addition of tyrosine kinase inhibitors to their treatment regimen is currently being ex...
Guardat en:
| Autors principals: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2025-08-01
|
| Col·lecció: | Blood Neoplasia |
| Accés en línia: | http://www.sciencedirect.com/science/article/pii/S2950328025000445 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|